Position in AQST
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$212,376
+$55,154 QoQ
Shares Held
51,052
+34.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 185 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $19,819,101 across 9 Drug Manufacturers - Specialty & Generic names. AQST ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
116,275 | $8,355,521 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
47,800 | $8,056,212 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,090 | $1,674,254 | |
| 4 | VTRS |
Viatris Inc
|
29,649 | $470,826 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,574 | $324,367 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,757 | $305,861 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
8,973 | $220,825 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
This page
|
51,052 | $212,376 |
All Filings in AQST
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,376 | 51,052 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $157,222 | 37,885 | Shares | Sole | 2026-04-24 | |
| 2025-09-30 | $187,443 | 33,532 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||